Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chamberland

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Melanoma Research|September 28, 2011
Insulin resistance in relation to melanoma riskAntonios G Antoniadis, Eleni Th Petridou, Constantine N Antonopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2011
Leptin is an effective treatment for hypothalamic amenorrheaSharon H Chou, John P Chamberland, Xiaowen Liu, et al.
Metabolism: Clinical and Experimental|July 12, 2011
Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic womenElizabeth Sienkiewicz, Faidon Magkos, Konstantinos N Aronis, et al.
Journal of Applied Clinical Medical Physics|July 14, 2025
Novel validation of HDR brachy therapy dosimetry for cervical cancer using egs_brachy Monte Carlo simulations: a comparative analysis with Oncentra treatment planning systemDuong Thanh Tai, Nguyen Thi Anh Thu, Tran Thien Thanh, et al.
Metabolism: Clinical and Experimental|April 15, 2014
Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism StudyXiaowen Liu, Ole-Petter R Hamnvik, John P Chamberland, et al.
European Journal of Endocrinology|September 3, 2011
Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism StudyXiaowen Liu, Ole-Petter R Hamnvik, Michael Petrou, et al.
Metabolism: Clinical and Experimental|November 9, 2010
Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort StudyOle-Petter R Hamnvik, Xiaowen Liu, Michael Petrou, et al.
Gut|June 28, 2012
Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in miceHyun-Seuk Moon, Xiaowen Liu, Jutta M Nagel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2011
Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studiesNicholas Mitsiades, Kalliopi Pazaitou-Panayiotou, Konstantinos N Aronis, et al.
European Journal of Endocrinology|September 25, 2013
Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humansMaria T Vamvini, Konstantinos N Aronis, Grigorios Panagiotou, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Melanoma Research|September 28, 2011
Insulin resistance in relation to melanoma riskAntonios G Antoniadis, Eleni Th Petridou, Constantine N Antonopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2011
Leptin is an effective treatment for hypothalamic amenorrheaSharon H Chou, John P Chamberland, Xiaowen Liu, et al.
Metabolism: Clinical and Experimental|July 12, 2011
Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic womenElizabeth Sienkiewicz, Faidon Magkos, Konstantinos N Aronis, et al.
Journal of Applied Clinical Medical Physics|July 14, 2025
Novel validation of HDR brachy therapy dosimetry for cervical cancer using egs_brachy Monte Carlo simulations: a comparative analysis with Oncentra treatment planning systemDuong Thanh Tai, Nguyen Thi Anh Thu, Tran Thien Thanh, et al.
Metabolism: Clinical and Experimental|April 15, 2014
Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism StudyXiaowen Liu, Ole-Petter R Hamnvik, John P Chamberland, et al.
European Journal of Endocrinology|September 3, 2011
Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism StudyXiaowen Liu, Ole-Petter R Hamnvik, Michael Petrou, et al.
Metabolism: Clinical and Experimental|November 9, 2010
Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort StudyOle-Petter R Hamnvik, Xiaowen Liu, Michael Petrou, et al.
Gut|June 28, 2012
Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in miceHyun-Seuk Moon, Xiaowen Liu, Jutta M Nagel, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2011
Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studiesNicholas Mitsiades, Kalliopi Pazaitou-Panayiotou, Konstantinos N Aronis, et al.
European Journal of Endocrinology|September 25, 2013
Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humansMaria T Vamvini, Konstantinos N Aronis, Grigorios Panagiotou, et al.
Pageof 6